Rocket Lab (RKLB) Stock Gains Following Maiden European Space Agency Mission Success

Key Highlights

• Rocket Lab successfully executed its inaugural dedicated mission for the European Space Agency (ESA) on March 28.
• The “Daughter Of The Stars” mission placed ESA’s “Celeste” payload into low Earth orbit at a 510 km altitude.
• This marked the company’s sixth orbital mission of 2026 and the 85th successful Electron rocket deployment to date.
• The aerospace firm secured a record-breaking $190 million contract with the U.S. Department of War for 20 hypersonic test missions, elevating its total backlog beyond $2 billion.
• Analysts maintain a Moderate Buy rating on RKLB shares with a consensus price target of $89.36, suggesting approximately 47% potential upside.

Rocket Lab achieved a significant milestone on Friday evening by executing its inaugural dedicated mission for the European Space Agency, successfully deploying navigation test satellites from its New Zealand facility. The Electron launch vehicle departed from Launch Complex 1 at 10:14 p.m. New Zealand Time on March 28, transporting ESA’s “Celeste” payload to a 510-kilometer altitude in low Earth orbit.

Dubbed “Daughter Of The Stars,” this mission represents the company’s sixth orbital deployment in 2026 and brings the total Electron vehicle mission count to 85.

The pair of satellites will evaluate whether a constellation operating in low Earth orbit can effectively complement Europe’s Galileo navigation infrastructure, which functions in medium Earth orbit. The objective is enhancing positioning precision throughout Europe for applications spanning autonomous transportation, maritime operations, and emergency response systems.

Two European industry partnerships constructed the spacecraft — one spearheaded by GMV based in Spain, and another led by Thales Alenia Space headquartered in France.

Rocket Lab USA, Inc., RKLB

RKLB stock advanced approximately 2% during Monday’s premarket session following the mission announcement.

Shares have declined 13% since the start of the year, affected by widespread risk-averse market behavior and escalating U.S.-Iran tensions. Despite this, the stock has surged 231% over the trailing twelve-month period.

Major Defense Contract Strengthens Position

Beyond the ESA achievement, Rocket Lab recently won a substantial $190 million agreement with the U.S. Department of War to conduct 20 hypersonic test missions utilizing its HASTE launch platform. This represents the largest individual contract in the company’s history.

This agreement propelled Rocket Lab’s cumulative backlog beyond the $2 billion threshold.

Throughout the remainder of 2026, the company has scheduled missions encompassing commercial Earth observation operations, national security deployments, international space agency partnerships, and hypersonic technology advancement initiatives.

Neutron Rocket Remains Key Catalyst

This operational momentum builds toward the highly anticipated inaugural launch of Rocket Lab’s larger Neutron rocket, presently scheduled for late 2026.

Neutron is engineered to compete in the medium-lift segment, focusing on reusable launch capabilities for larger commercial and governmental payloads.

Analysts assign a Moderate Buy consensus rating to RKLB, comprising nine Buy recommendations and four Hold ratings. The mean price target stands at $89.36 — representing approximately 47% upside potential from present trading levels.

The post Rocket Lab (RKLB) Stock Gains Following Maiden European Space Agency Mission Success appeared first on Blockonomi.